News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
100,592 Results
Type
Article (5992)
Company Profile (2)
Press Release (94598)
Multimedia
Podcasts (1)
Webinars (2)
Section
Business (31254)
Career Advice (169)
Deals (5587)
Drug Delivery (13)
Drug Development (12355)
Employer Resources (9)
FDA (2438)
Job Trends (2302)
News (52736)
Policy (5330)
Tag
2024 BioCapital Digital (1)
Academia (313)
Accelerated approval (2)
Adcomms (2)
Allergies (14)
Alliances (5816)
ALS (25)
Alzheimer's disease (228)
Antibody-drug conjugate (ADC) (29)
Approvals (2421)
Artificial intelligence (33)
Autoimmune disease (3)
Automation (4)
Bankruptcy (59)
Best Places to Work (1916)
Biosimilars (22)
Biotechnology (2)
Bladder cancer (7)
Brain cancer (9)
Breast cancer (53)
Cancer (529)
Cardiovascular disease (45)
Career advice (130)
CAR-T (13)
Cell therapy (64)
Cervical cancer (6)
Clinical research (10538)
Collaboration (156)
Compensation (72)
Complete response letters (7)
COVID-19 (419)
CRISPR (11)
C-suite (55)
Cystic fibrosis (7)
Data (588)
Depression (12)
Diabetes (54)
Diagnostics (1054)
Digital health (2)
Diversity (1)
Diversity, equity & inclusion (3)
Drug discovery (25)
Drug pricing (16)
Drug shortages (16)
Duchenne muscular dystrophy (22)
Earnings (17031)
Editorial (12)
Employer resources (8)
Events (16572)
Executive appointments (113)
FDA (2674)
Funding (132)
Gene editing (30)
Generative AI (3)
Gene therapy (80)
GLP-1 (137)
Government (665)
Guidances (12)
Healthcare (2866)
Huntington's disease (7)
IgA nephropathy (15)
Immunology and inflammation (31)
Indications (9)
Infectious disease (467)
Inflammatory bowel disease (27)
Inflation Reduction Act (2)
Influenza (15)
Intellectual property (28)
Interviews (28)
IPO (2966)
IRA (4)
Job creations (504)
Job search strategy (119)
Kidney cancer (6)
Labor market (8)
Layoffs (110)
Legal (1274)
Liver cancer (15)
Lung cancer (84)
Lymphoma (40)
Management (4)
Manufacturing (61)
MASH (24)
Medical device (2290)
Medtech (2290)
Mergers & acquisitions (2734)
Metabolic disorders (136)
Multiple sclerosis (18)
NASH (10)
Neurodegenerative disease (35)
Neuropsychiatric disorders (6)
Neuroscience (345)
NextGen: Class of 2025 (958)
Non-profit (598)
Northern California (438)
Obesity (70)
Opinion (16)
Ovarian cancer (13)
Pain (23)
Pancreatic cancer (9)
Parkinson's disease (33)
Partnered (2)
Patents (37)
Patient recruitment (22)
Peanut (7)
People (7237)
Pharmaceutical (4)
Pharmacy benefit managers (2)
Phase I (2926)
Phase II (4482)
Phase III (3988)
Pipeline (304)
Policy (18)
Postmarket research (401)
Preclinical (1087)
Prostate cancer (34)
Psychedelics (4)
Radiopharmaceuticals (47)
Rare diseases (81)
Real estate (758)
Recruiting (2)
Regulatory (3813)
Reports (8)
Research institute (247)
Resumes & cover letters (27)
Rett syndrome (1)
RNA editing (2)
RSV (15)
Schizophrenia (11)
Series A (16)
Series B (19)
Sickle cell disease (18)
Southern California (355)
Special edition (8)
Spinal muscular atrophy (24)
Sponsored (5)
Startups (427)
Stomach cancer (1)
Supply chain (16)
Tariffs (1)
The Weekly (1)
United States (3942)
Vaccines (136)
Venture capitalists (8)
Weight loss (41)
Women's health (3)
Worklife (2)
Date
Last 7 days (34)
Last 30 days (162)
Last 365 days (5421)
2025 (885)
2024 (5574)
2023 (6420)
2022 (6506)
2021 (7450)
2020 (7961)
2019 (7853)
2018 (6406)
2017 (5335)
2016 (4296)
2015 (5296)
2014 (4638)
2013 (3506)
2012 (3423)
2011 (3524)
2010 (3855)
Location
Africa (93)
Alabama (10)
Arizona (30)
Arkansas (1)
Asia (6181)
Australia (1088)
California (954)
Canada (357)
China (93)
Colorado (51)
Connecticut (39)
Delaware (22)
Europe (14817)
Florida (154)
Georgia (47)
Idaho (7)
Illinois (84)
India (5)
Indiana (65)
Japan (36)
Kansas (11)
Kentucky (6)
Maine (10)
Maryland (158)
Massachusetts (798)
Michigan (28)
Minnesota (49)
Mississippi (1)
Missouri (11)
Montana (4)
Nevada (10)
New Hampshire (8)
New Jersey (376)
New Mexico (3)
New York (327)
North Carolina (142)
North Dakota (1)
Northern California (438)
Ohio (26)
Oklahoma (4)
Oregon (5)
Pennsylvania (243)
Puerto Rico (3)
Rhode Island (6)
South America (148)
South Carolina (3)
Southern California (355)
Tennessee (11)
Texas (167)
Utah (35)
Virginia (18)
Washington D.C. (7)
Washington State (90)
West Virginia (1)
Wisconsin (13)
100,592 Results for "oct".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Cagent Vascular Initiates Patient Enrollment in the Serranator® vs. POBA OCT Study at Columbia University Medical Center
April 10, 2025
·
2 min read
Press Releases
OCT Holdings Announces Rebrand to Octavian Therapeutics, Appointment of New Chair and Fundraising Launch
February 11, 2025
·
6 min read
Press Releases
Perimeter Announces B-Series OCT with ImgAssist AI 2.0 Pivotal Trial Accepted for Presentation at the 2025 Annual Meeting of the American Society of Breast Surgeons
March 5, 2025
·
7 min read
Biotech Beach
n-Lorem Foundation Announces the Second Annual Nano-rare Patient Colloquium Will be Held on Oct. 30 & 31, 2024
n-Lorem, a nonprofit foundation , has announced the dates for its second annual Nano-rare Patient Colloquium, which will be held Oct. 30 & 31 in Cambridge, Mass.
April 10, 2024
·
3 min read
Press Releases
Acumen Pharmaceuticals to Host Virtual R&D Day on Oct. 2, 2024
September 26, 2024
·
2 min read
Press Releases
Merck to Hold Third-Quarter 2024 Sales and Earnings Conference Call Oct. 31
October 1, 2024
·
3 min read
News
Co-Diagnostics, Inc. to Host Booth at Medlab Africa in Cape Town on Oct 22-24, 2024
October 21, 2024
·
3 min read
Press Releases
Perimeter B-Series OCT with ImgAssist AI 2.0 Demonstrates Super-Superiority Compared to Standard-of-Care in Pivotal Clinical Trial
November 21, 2024
·
8 min read
Press Releases
Gentuity® HF-OCT Imaging System Receives FDA 510(k) Clearance for Pre- and Post-Coronary Intervention Imaging
October 22, 2024
·
4 min read
Business
ADM to Release Third Quarter Financial Results Oct. 24, 2023
ADM (NYSE: ADM) will release financial results for the third quarter of 2023 before the market opens on Tuesday, Oct. 24, 2023.
October 10, 2023
·
1 min read
1 of 10,060
Next
